A	O
randomized	B:C0206034
trial	I:C0206034
of	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
and	O
0.9	O
%	O
sodium	O
chloride	O
in	O
acute	O
pediatric	I:C0267446
gastroenteritis	I:C0267446
.	O

A	O
randomized	O
trial	I:C0206034
of	O
Plasma	B:C0071213
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
and	O
0.9	O
%	O
sodium	O
chloride	O
in	O
acute	O
pediatric	I:C0267446
gastroenteritis	I:C0267446
.	O

A	O
randomized	O
trial	I:C0206034
of	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
and	O
0.9	O
%	O
sodium	O
chloride	O
in	O
acute	B:C0267446
pediatric	I:C0267446
gastroenteritis	I:C0267446
.	O

Compare	O
the	O
efficacy	O
and	O
safety	O
of	O
Plasma	B:C0071213
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
(	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
)	O
versus	O
0.9	O
%	O
sodium	O
chloride	O
(	O
NaCl	O
)	O
intravenous	O
(	I:C0559692
IV	I:C0559692
)	I:C0559692
fluid	I:C0559692
replacement	I:C0559692
in	O
children	O
with	O
moderate	O
to	O
severe	O
dehydration	I:C3472181
secondary	O
to	O
acute	O
gastroenteritis	I:C0267446
(	O
acute	O
gastroenteritis	I:C0267446
)	O
.	O

Compare	O
the	O
efficacy	O
and	O
safety	O
of	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
(	O
Plasma	B:C0071213
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
)	O
versus	O
0.9	O
%	O
sodium	O
chloride	O
(	O
NaCl	O
)	O
intravenous	O
(	I:C0559692
IV	I:C0559692
)	I:C0559692
fluid	I:C0559692
replacement	I:C0559692
in	O
children	O
with	O
moderate	O
to	O
severe	O
dehydration	I:C3472181
secondary	O
to	O
acute	O
gastroenteritis	I:C0267446
(	O
acute	O
gastroenteritis	I:C0267446
)	O
.	O

Compare	O
the	O
efficacy	O
and	O
safety	O
of	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
(	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
)	O
versus	O
0.9	O
%	O
sodium	O
chloride	O
(	O
NaCl	O
)	O
intravenous	B:C0559692
(	I:C0559692
IV	I:C0559692
)	I:C0559692
fluid	I:C0559692
replacement	I:C0559692
in	O
children	O
with	O
moderate	O
to	O
severe	O
dehydration	I:C3472181
secondary	O
to	O
acute	O
gastroenteritis	I:C0267446
(	O
acute	O
gastroenteritis	I:C0267446
)	O
.	O

Compare	O
the	O
efficacy	O
and	O
safety	O
of	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
(	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
)	O
versus	O
0.9	O
%	O
sodium	O
chloride	O
(	O
NaCl	O
)	O
intravenous	O
(	I:C0559692
IV	I:C0559692
)	I:C0559692
fluid	I:C0559692
replacement	I:C0559692
in	O
children	O
with	O
moderate	O
to	O
severe	B:C3472181
dehydration	I:C3472181
secondary	O
to	O
acute	O
gastroenteritis	I:C0267446
(	O
acute	O
gastroenteritis	I:C0267446
)	O
.	O

Compare	O
the	O
efficacy	O
and	O
safety	O
of	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
(	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
)	O
versus	O
0.9	O
%	O
sodium	O
chloride	O
(	O
NaCl	O
)	O
intravenous	O
(	I:C0559692
IV	I:C0559692
)	I:C0559692
fluid	I:C0559692
replacement	I:C0559692
in	O
children	O
with	O
moderate	O
to	O
severe	O
dehydration	I:C3472181
secondary	O
to	O
acute	B:C0267446
gastroenteritis	I:C0267446
(	O
acute	O
gastroenteritis	I:C0267446
)	O
.	O

Compare	O
the	O
efficacy	O
and	O
safety	O
of	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
(	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
)	O
versus	O
0.9	O
%	O
sodium	O
chloride	O
(	O
NaCl	O
)	O
intravenous	O
(	I:C0559692
IV	I:C0559692
)	I:C0559692
fluid	I:C0559692
replacement	I:C0559692
in	O
children	O
with	O
moderate	O
to	O
severe	O
dehydration	I:C3472181
secondary	O
to	O
acute	O
gastroenteritis	I:C0267446
(	O
acute	B:C0267446
gastroenteritis	I:C0267446
)	O
.	O

Prospective	B:C0033522
,	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
study	I:C0013072
conducted	O
at	O
eight	O
pediatric	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
in	O
the	O
US	O
and	O
Canada	O
(	O
NCT#01234883	O
)	O
.	O

Prospective	O
,	O
randomized	B:C0034656
,	O
double	O
-	I:C0013072
blind	I:C0013072
study	I:C0013072
conducted	O
at	O
eight	O
pediatric	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
in	O
the	O
US	O
and	O
Canada	O
(	O
NCT#01234883	O
)	O
.	O

Prospective	O
,	O
randomized	O
,	O
double	B:C0013072
-	I:C0013072
blind	I:C0013072
study	I:C0013072
conducted	O
at	O
eight	O
pediatric	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
in	O
the	O
US	O
and	O
Canada	O
(	O
NCT#01234883	O
)	O
.	O

Prospective	O
,	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
study	I:C0013072
conducted	O
at	O
eight	O
pediatric	O
emergency	B:C0562508
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
in	O
the	O
US	O
and	O
Canada	O
(	O
NCT#01234883	O
)	O
.	O

Prospective	O
,	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
study	I:C0013072
conducted	O
at	O
eight	O
pediatric	O
emergency	O
departments	I:C0562508
(	O
emergency	B:C0562508
departments	I:C0562508
)	O
in	O
the	O
US	O
and	O
Canada	O
(	O
NCT#01234883	O
)	O
.	O

Prospective	O
,	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
study	I:C0013072
conducted	O
at	O
eight	O
pediatric	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
in	O
the	O
US	B:C0041703
and	O
Canada	O
(	O
NCT#01234883	O
)	O
.	O

Prospective	O
,	O
randomized	O
,	O
double	O
-	I:C0013072
blind	I:C0013072
study	I:C0013072
conducted	O
at	O
eight	O
pediatric	O
emergency	O
departments	I:C0562508
(	O
emergency	O
departments	I:C0562508
)	O
in	O
the	O
US	O
and	O
Canada	B:C0006823
(	O
NCT#01234883	O
)	O
.	O

The	O
primary	O
outcome	O
measure	O
was	O
serum	B:C1261426
bicarbonate	I:C1261426
level	I:C1261426
at	O
4	O
h	O
.	O

Secondary	O
outcomes	O
included	O
safety	O
and	O
tolerability	B:C3274448
.	O

The	O
hypothesis	O
was	O
that	O
Plasma	B:C0071213
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
would	O
be	O
superior	O
to	O
0.9	O
%	O
NaCl	O
in	O
improvement	O
of	I:C0202059
4-h	I:C0202059
bicarbonate	I:C0202059
.	O

The	O
hypothesis	O
was	O
that	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
would	O
be	O
superior	O
to	O
0.9	O
%	O
NaCl	O
in	O
improvement	B:C0202059
of	I:C0202059
4-h	I:C0202059
bicarbonate	I:C0202059
.	O

Patients	O
(	O
n	O
=	O
100	O
)	O
aged	O
≥	O
6	O
months	O
to	O
<	O
11	O
years	O
with	O
acute	B:C0267446
gastroenteritis	I:C0267446
-	O
induced	O
moderate	O
-	O
to-	O
severe	O
dehydration	I:C3472181
were	O
enrolled	O
.	O

Patients	O
(	O
n	O
=	O
100	O
)	O
aged	O
≥	O
6	O
months	O
to	O
<	O
11	O
years	O
with	O
acute	O
gastroenteritis	I:C0267446
-	O
induced	O
moderate	O
-	O
to-	O
severe	B:C3472181
dehydration	I:C3472181
were	O
enrolled	O
.	O

Patients	O
with	O
a	O
baseline	O
bicarbonate	B:C0428196
level	I:C0428196
≤	O
22	O
mEq	O
/	O
L	O
formed	O
the	O
modified	O
intent	O
to	O
treat	O
(	O
mITT	O
)	O
group	O
.	O

Patients	O
with	O
a	O
baseline	O
bicarbonate	O
level	I:C0428196
≤	O
22	O
mEq	O
/	O
L	O
formed	O
the	O
modified	O
intent	O
to	O
treat	O
(	O
mITT	O
)	O
group	B:C1257890
.	O

At	O
baseline	O
,	O
the	O
treatment	B:C0087111
groups	O
were	O
comparable	O
except	O
that	O
the	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	O
was	O
older	O
.	O

At	O
baseline	O
,	O
the	O
treatment	O
groups	B:C1257890
were	O
comparable	O
except	O
that	O
the	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	O
was	O
older	O
.	O

At	O
baseline	O
,	O
the	O
treatment	O
groups	O
were	O
comparable	O
except	O
that	O
the	O
Plasma	B:C0071213
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	O
was	O
older	O
.	O

At	O
baseline	O
,	O
the	O
treatment	O
groups	O
were	O
comparable	O
except	O
that	O
the	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	B:C1257890
was	O
older	O
.	O

At	O
hour	O
4	O
,	O
the	O
Plasma	B:C0071213
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	O
had	O
greater	O
increases	O
in	I:C0858078
serum	I:C0858078
bicarbonate	I:C0858078
from	O
baseline	O
than	O
did	O
the	O
0.9	O
%	O
NaCl	O
group	O
(	O
mean	O
±	O
SD	O
at	O
4	O
h	O
:	O
18	O
±	O
3.74	O
vs	O
18.0	O
±	O
3.67	O
;	O
change	O
from	O
baseline	O
of	O
1.6	O
and	O
0.0	O
,	O
respectively	O
;	O
P	O
=	O
.004	O
)	O
.	O

At	O
hour	O
4	O
,	O
the	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	B:C1257890
had	O
greater	O
increases	O
in	I:C0858078
serum	I:C0858078
bicarbonate	I:C0858078
from	O
baseline	O
than	O
did	O
the	O
0.9	O
%	O
NaCl	O
group	O
(	O
mean	O
±	O
SD	O
at	O
4	O
h	O
:	O
18	O
±	O
3.74	O
vs	O
18.0	O
±	O
3.67	O
;	O
change	O
from	O
baseline	O
of	O
1.6	O
and	O
0.0	O
,	O
respectively	O
;	O
P	O
=	O
.004	O
)	O
.	O

At	O
hour	O
4	O
,	O
the	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	O
had	O
greater	O
increases	B:C0858078
in	I:C0858078
serum	I:C0858078
bicarbonate	I:C0858078
from	O
baseline	O
than	O
did	O
the	O
0.9	O
%	O
NaCl	O
group	O
(	O
mean	O
±	O
SD	O
at	O
4	O
h	O
:	O
18	O
±	O
3.74	O
vs	O
18.0	O
±	O
3.67	O
;	O
change	O
from	O
baseline	O
of	O
1.6	O
and	O
0.0	O
,	O
respectively	O
;	O
P	O
=	O
.004	O
)	O
.	O

At	O
hour	O
4	O
,	O
the	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	O
had	O
greater	O
increases	O
in	I:C0858078
serum	I:C0858078
bicarbonate	I:C0858078
from	O
baseline	O
than	O
did	O
the	O
0.9	O
%	O
NaCl	O
group	B:C1257890
(	O
mean	O
±	O
SD	O
at	O
4	O
h	O
:	O
18	O
±	O
3.74	O
vs	O
18.0	O
±	O
3.67	O
;	O
change	O
from	O
baseline	O
of	O
1.6	O
and	O
0.0	O
,	O
respectively	O
;	O
P	O
=	O
.004	O
)	O
.	O

Both	O
treatment	B:C0087111
groups	O
received	O
similar	O
fluid	O
volumes	O
.	O

Both	O
treatment	O
groups	B:C1257890
received	O
similar	O
fluid	O
volumes	O
.	O

The	O
Plasma	B:C0071213
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	O
had	O
less	O
abdominal	O
pain	I:C0000737
and	O
better	O
dehydration	O
scores	O
at	O
hour	O
2	O
(	O
both	O
P	O
=	O
.03	O
)	O
but	O
not	O
at	O
hour	O
4	O
(	O
P	O
=	O
0.15	O
and	O
0.08	O
,	O
respectively	O
)	O
.	O

The	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	B:C1257890
had	O
less	O
abdominal	O
pain	I:C0000737
and	O
better	O
dehydration	O
scores	O
at	O
hour	O
2	O
(	O
both	O
P	O
=	O
.03	O
)	O
but	O
not	O
at	O
hour	O
4	O
(	O
P	O
=	O
0.15	O
and	O
0.08	O
,	O
respectively	O
)	O
.	O

The	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	O
had	O
less	O
abdominal	B:C0000737
pain	I:C0000737
and	O
better	O
dehydration	O
scores	O
at	O
hour	O
2	O
(	O
both	O
P	O
=	O
.03	O
)	O
but	O
not	O
at	O
hour	O
4	O
(	O
P	O
=	O
0.15	O
and	O
0.08	O
,	O
respectively	O
)	O
.	O

The	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
group	O
had	O
less	O
abdominal	O
pain	I:C0000737
and	O
better	O
dehydration	B:C0011175
scores	O
at	O
hour	O
2	O
(	O
both	O
P	O
=	O
.03	O
)	O
but	O
not	O
at	O
hour	O
4	O
(	O
P	O
=	O
0.15	O
and	O
0.08	O
,	O
respectively	O
)	O
.	O

No	O
patient	O
experienced	O
clinically	O
relevant	O
worsening	O
of	O
laboratory	B:C0587081
findings	I:C0587081
or	O
physical	O
examination	I:C0031809
,	O
and	O
hospital	O
admission	O
rates	O
were	O
similar	O
.	O

No	O
patient	O
experienced	O
clinically	O
relevant	O
worsening	O
of	O
laboratory	O
findings	I:C0587081
or	O
physical	B:C0031809
examination	I:C0031809
,	O
and	O
hospital	O
admission	O
rates	O
were	O
similar	O
.	O

One	O
patient	O
in	O
each	O
treatment	B:C0087111
group	O
developed	O
hyponatremia	O
.	O

One	O
patient	O
in	O
each	O
treatment	O
group	B:C1257890
developed	O
hyponatremia	O
.	O

One	O
patient	O
in	O
each	O
treatment	O
group	O
developed	O
hyponatremia	B:C0020625
.	O

Four	O
patients	O
developed	O
hyperkalemia	B:C0020461
(	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
:1	O
,	O
0.9	O
%	O
NaCl	O
:	O
3	O
)	O
.	O

Four	O
patients	O
developed	O
hyperkalemia	O
(	O
Plasma	B:C0071213
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
:1	O
,	O
0.9	O
%	O
NaCl	O
:	O
3	O
)	O
.	O

In	O
comparison	O
with	O
0.9	O
%	O
NaCl	O
,	O
Plasma	B:C0071213
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
for	O
rehydration	O
in	O
children	O
with	O
acute	O
gastroenteritis	I:C0267446
was	O
well	O
tolerated	O
and	O
led	O
to	O
more	O
rapid	O
improvement	O
in	I:C0428301
serum	I:C0428301
bicarbonate	I:C0428301
and	O
dehydration	O
score	O
.	O

In	O
comparison	O
with	O
0.9	O
%	O
NaCl	O
,	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
for	O
rehydration	B:C0034997
in	O
children	O
with	O
acute	O
gastroenteritis	I:C0267446
was	O
well	O
tolerated	O
and	O
led	O
to	O
more	O
rapid	O
improvement	O
in	I:C0428301
serum	I:C0428301
bicarbonate	I:C0428301
and	O
dehydration	O
score	O
.	O

In	O
comparison	O
with	O
0.9	O
%	O
NaCl	O
,	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
for	O
rehydration	O
in	O
children	O
with	O
acute	B:C0267446
gastroenteritis	I:C0267446
was	O
well	O
tolerated	O
and	O
led	O
to	O
more	O
rapid	O
improvement	O
in	I:C0428301
serum	I:C0428301
bicarbonate	I:C0428301
and	O
dehydration	O
score	O
.	O

In	O
comparison	O
with	O
0.9	O
%	O
NaCl	O
,	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
for	O
rehydration	O
in	O
children	O
with	O
acute	O
gastroenteritis	I:C0267446
was	O
well	O
tolerated	O
and	O
led	O
to	O
more	O
rapid	O
improvement	B:C0428301
in	I:C0428301
serum	I:C0428301
bicarbonate	I:C0428301
and	O
dehydration	O
score	O
.	O

In	O
comparison	O
with	O
0.9	O
%	O
NaCl	O
,	O
Plasma	O
-	I:C0071213
Lyte	I:C0071213
A	I:C0071213
for	O
rehydration	O
in	O
children	O
with	O
acute	O
gastroenteritis	I:C0267446
was	O
well	O
tolerated	O
and	O
led	O
to	O
more	O
rapid	O
improvement	O
in	I:C0428301
serum	I:C0428301
bicarbonate	I:C0428301
and	O
dehydration	B:C0011175
score	O
.	O

